Giving highest priority to ensure uninterrupted supply of medicines: Sharad Tyagi, Boehringer Ingelheim, India Read more
Clinical trials on zinc usage initiated for treatment of patients with severe symptoms of COVID-19 Read more
While the market is bleeding, pharma sector has withstood the lock-down. Can it be a good bet for investors? Read more
DBT and BIRAC recommend 16 proposals for funding support towards COVID-19 Research Consortium Read more